TFC Financial Management, Inc.
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1827844
BOSTON, MA
Position in ALNY
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$23,822
-$4,808 QoQ
Shares Held
72
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TFC Financial Management, Inc. holds $402,102 across 44 Biotechnology names. ALNY ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
307 | $137,087 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
104 | $80,354 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
688 | $32,728 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
1,550 | $32,426 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
72 | $23,822 | |
| 6 | MRNA |
Moderna, Inc.
|
319 | $16,205 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
211 | $13,636 | |
| 8 | OCUL |
Ocular Therapeutix, Inc
|
1,352 | $11,451 |
All Filings in ALNY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,822 | 72 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $28,630 | 72 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $33,744 | 74 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $24,130 | 74 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $19,981 | 74 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $17,412 | 74 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $20,352 | 74 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $13,122 | 54 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $7,621 | 51 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $9,570 | 50 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $8,855 | 50 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $9,497 | 50 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $25,040 | 125 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $29,706 | 125 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $25,020 | 125 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $18,231 | 125 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $20,411 | 125 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $21,197 | 125 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $23,601 | 125 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $21,190 | 125 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $17,648 | 125 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $16,246 | 125 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $18,200 | 125 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||